Brief: Neurosense Therapeutics Plans To File For Early Commercialization Of ALS Treatment In Canada

Neurosense Therapeutics

09/10/2024 14:10

Oct 9 (Reuters) - Neurosense Therapeutics Ltd  NRSN.O :
    * NEUROSENSE THERAPEUTICS PLANS TO FILE FOR EARLY
COMMERCIALIZATION OF ALS TREATMENT IN CANADA
    * NEUROSENSE THERAPEUTICS: PLANS TO SEEK APPROVAL IN
ADDITIONAL
COUNTRIES

Source text for Eikon:  ID:nPn8RbJ23a 
Further company coverage:  NRSN.O 

 ((Reuters.Briefs@thomsonreuters.com;))